Javier A. Cambronero
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial.
Journal: Therapeutic advances in urology
Published: October 08, 2015
Bilateral acute cortical necrosis and severe acute pancreatitis.
Journal: Medicina intensiva
Published: October 02, 2015
How should we address the diagnosis of overactive bladder in women?
Journal: Actas urologicas espanolas
Published: June 09, 2015
Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial.
Journal: BMC urology
Published: June 14, 2013
Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies.
Journal: International journal of clinical practice
Published: February 20, 2013
Validation of the Spanish version of the questionnaire «Benefit, satisfaction and willingness to continue the treatment» in patients with overactive bladder.
Journal: Actas urologicas espanolas
Published: January 30, 2013
Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial.
Journal: European urology
Published: September 07, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026